| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | Jun 16, 2025 | Accustem Sciences Inc. | Director | Buy | 47.5 | +2,400 | 0.04% | ✗ | $2.4K |
| Jun 11, 2025 | Jun 13, 2025 | Accustem Sciences Inc. | Director | Buy | 68.8 | +37,196 | 0.58% | ✗ | $18.5K |
| Apr 8, 2025 | Apr 10, 2025 | Accustem Sciences Inc. | Director | Buy | 68.8 | +38,000 | 0.78% | ✗ | $25.3K |
| Mar 18, 2025 | Apr 8, 2025 | Accustem Sciences Inc. | Director | Buy | 87.5 | +152,802 | 3.24% | ✗ | $78.3K |
| Dec 31, 2024 | Jan 3, 2025 | Accustem Sciences Inc. | Director | Buy | 78.8 | +100,000 | 2.16% | ✗ | $38.1K |
| Oct 23, 2023 | Oct 31, 2023 | OKYO Pharma Ltd | Chair | Buy | 92.5 | +569,539 | 6.62% | ✗ | $854.3K |
| Dec 30, 2022 | Jan 3, 2023 | Accustem Sciences Inc. | Director | Buy | 55.0 | +5,000 | 0.13% | ✗ | $7K |
| Dec 2, 2022 | Dec 5, 2022 | Accustem Sciences Inc. | Director | Buy | 55.0 | +3,729 | 0.10% | ✗ | $5.3K |
| Nov 18, 2022 | Nov 22, 2022 | Accustem Sciences Inc. | Director | Buy | 68.8 | +24,500 | 0.64% | ✗ | $25.7K |
| Aug 1, 2022 | Aug 2, 2022 | Accustem Sciences Inc. | Director | Buy | 60.0 | +10,000 | 0.26% | ✗ | $7.9K |
| Jun 8, 2022 | Jun 9, 2022 | Accustem Sciences Inc. | Director | Buy | 68.8 | +20,000 | 0.53% | ✗ | $10K |
| May 19, 2022 | May 20, 2022 | OKYO Pharma Ltd | Chair | Buy | 85.0 | +5,800,000 | 1.07% | ✗ | $440.8K |
| May 19, 2022 | May 19, 2022 | OKYO Pharma Ltd | Chair | Buy | 95.0 | +37,500 | 150.00% | ✗ | $150K |
| May 17, 2022 | May 18, 2022 | OKYO Pharma Ltd | Chair | Buy | 95.0 | +25,000 | 100.00% | ✗ | $96.8K |
| May 17, 2022 | May 18, 2022 | OKYO Pharma Ltd | Chair | Buy | 65.0 | +1,625,000 | 0.30% | ✗ | $96.7K |
| Apr 25, 2022 | Apr 27, 2022 | Accustem Sciences Inc. | Director | Buy | 61.3 | +9,447 | 0.25% | ✗ | $13.5K |